NYSEMKT: NRXSNeuraxis Inc Stock Ownership - Who owns Neuraxis?
Insider buying vs selling
Have Neuraxis Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Brian Hannasch | 10% Owner | 2025-07-01 | 355,556 | $2.25 | $800.00kBuy |
| Masimo Corp | 10% Owner | 2025-07-01 | 531,548 | $2.25 | $1.20MSell |
| Masimo Corp | 10% Owner | 2025-07-01 | 289,779 | $2.25 | $652.00kSell |
| Brian Hannasch | 10% Owner | 2025-04-21 | 18,065 | $1.73 | $31.25kBuy |
NRXS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when NRXS insiders and whales buy or sell their stock.
NRXS Shareholders
What type of owners hold Neuraxis Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Brian Hannasch | 15.68% | 1,131,522 | $2.73M | Insider |
| Christopher Robin Brown | 10.99% | 792,837 | $1.91M | Insider |
| Creative Planning | 7.65% | 551,668 | $1.33M | Institution |
| Gary Merril Peterson | 7.18% | 518,120 | $1.25M | Insider |
| Parsons Capital Management Inc | 1.62% | 116,726 | $281.31k | Institution |
| Bank Of Montreal | 1.48% | 106,476 | $256.61k | Institution |
| Vanguard Group Inc | 0.39% | 27,981 | $67.43k | Institution |
| Brian Allen Carrico | 0.38% | 27,118 | $65.35k | Insider |
| Citadel Advisors LLC | 0.37% | 26,821 | $64.64k | Institution |
| Stifel Financial Corp | 0.36% | 25,710 | $61.96k | Institution |
NRXS vs Biotech Stocks
Neuraxis Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.